SHO exhibited a fold change of 1.04 ± 0.02, representing a very slight increase, while SCH showed a slightly higher fold change of 1.13 ± 0.09, hinting at a potentially stronger interaction with ROS pathways. Here, SPRN is linked to spindle cell hemangioma.